Table 2.

Cell-cycle distribution of Ba/F3/kit WT and Ba/F3/kit cITD treated with IM and Rap



Ba/F3/kit WT

Ba/F3/kit cITD1
Viable cells in phase, %
Viable cells in phase, %
Drugs treated
G1
S
G2/M
Total apoptotic cells, %
G1
S
G2/M
Total apoptotic cells, %
DMSO, control         
   24 h   45.8   29.7   22.9   1.6   46.4   23.7   27.1   2.8  
   48 h   47.2   27.1   23.3   2.4   43.7   23.7   29.2   3.4  
50 nM IM         
   24 h   68.6   7.0   7.2   17.2   46.6   27.2   21.3   4.9  
   48 h   46.1   2.2   3.8   47.9   60.6   16.7   18   4.7  
5 nM Rap         
   24 h   44.4   25.2   19   11.4   57.4   19.8   17   5.8  
   48 h   48.9   14.7   11.3   25.1   72.1   9.1   9.5   9.3  
50 nM IM and 5 nM Rap         
   24 h   68.6   7.03   7.2   17.1   68.1   5.9   11.7   14.3  
   48 h
 
46.1
 
2.2
 
3.78
 
47.9
 
46
 
2.2
 
3.8
 
48
 


Ba/F3/kit WT

Ba/F3/kit cITD1
Viable cells in phase, %
Viable cells in phase, %
Drugs treated
G1
S
G2/M
Total apoptotic cells, %
G1
S
G2/M
Total apoptotic cells, %
DMSO, control         
   24 h   45.8   29.7   22.9   1.6   46.4   23.7   27.1   2.8  
   48 h   47.2   27.1   23.3   2.4   43.7   23.7   29.2   3.4  
50 nM IM         
   24 h   68.6   7.0   7.2   17.2   46.6   27.2   21.3   4.9  
   48 h   46.1   2.2   3.8   47.9   60.6   16.7   18   4.7  
5 nM Rap         
   24 h   44.4   25.2   19   11.4   57.4   19.8   17   5.8  
   48 h   48.9   14.7   11.3   25.1   72.1   9.1   9.5   9.3  
50 nM IM and 5 nM Rap         
   24 h   68.6   7.03   7.2   17.1   68.1   5.9   11.7   14.3  
   48 h
 
46.1
 
2.2
 
3.78
 
47.9
 
46
 
2.2
 
3.8
 
48
 

Ba/F3 WT and Ba/F3 kit cITD cells were treated with the indicated doses of IM and Rap, alone and in combination for 24 hours and 48 hours, respectively. Apoptosis was determined via analysis of DNA fragmentation of propidium iodide-stained nuclei

Close Modal

or Create an Account

Close Modal
Close Modal